Overview

Evidence-based recommendations on testing strategies for Lynch syndrome for people with endometrial cancer.

Last reviewed: 28 October 2020

Diagnostics guidance 42 has been migrated to HealthTech guidance 557.

Next review: This guidance will be reviewed if there is new evidence that is likely to change the recommendations.

Guidance development process

How we develop NICE HealthTech guidance